"Cell Line, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cell line derived from cultured tumor cells.
| Descriptor ID |
D045744
|
| MeSH Number(s) |
A11.251.210.190 A11.251.860.180
|
| Concept/Terms |
Cell Line, Tumor- Cell Line, Tumor
- Cell Lines, Tumor
- Line, Tumor Cell
- Lines, Tumor Cell
- Tumor Cell Lines
- Tumor Cell Line
|
Below are MeSH descriptors whose meaning is more general than "Cell Line, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Cell Line, Tumor".
This graph shows the total number of publications written about "Cell Line, Tumor" by people in this website by year, and whether "Cell Line, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 31 | 31 |
| 2004 | 0 | 61 | 61 |
| 2005 | 1 | 63 | 64 |
| 2006 | 0 | 66 | 66 |
| 2007 | 0 | 90 | 90 |
| 2008 | 0 | 77 | 77 |
| 2009 | 1 | 93 | 94 |
| 2010 | 1 | 104 | 105 |
| 2011 | 0 | 88 | 88 |
| 2012 | 1 | 111 | 112 |
| 2013 | 0 | 109 | 109 |
| 2014 | 1 | 129 | 130 |
| 2015 | 0 | 124 | 124 |
| 2016 | 0 | 118 | 118 |
| 2017 | 0 | 96 | 96 |
| 2018 | 0 | 90 | 90 |
| 2019 | 1 | 89 | 90 |
| 2020 | 0 | 68 | 68 |
| 2021 | 0 | 72 | 72 |
| 2022 | 0 | 20 | 20 |
| 2023 | 0 | 28 | 28 |
| 2024 | 0 | 65 | 65 |
| 2025 | 0 | 25 | 25 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Line, Tumor" by people in Profiles.
-
Dual Targeting EZH2 and Histone Deacetylases in Human Uterine Sarcoma Cells Under Both 2D and 3D Culture Conditions. J Cell Mol Med. 2025 Jun; 29(11):e70626.
-
Retrospective analysis and IMRT replanning of a 3D-CRT murine dose painting study for preclinical oxygen-guided radiotherapy. Sci Rep. 2025 May 22; 15(1):17755.
-
Telomerase reverse transcriptase degradation via a rationally designed covalent proteolysis targeting chimera. Bioorg Med Chem Lett. 2025 Sep 01; 125-126:130286.
-
3D genome organization shapes DNA damage susceptibility to platinum-based drugs. Nucleic Acids Res. 2025 May 22; 53(10).
-
Bispecific antibody targeting shared indel-derived neoantigen of APC. Front Immunol. 2025; 16:1574958.
-
Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire. J Immunother Cancer. 2025 May 02; 13(5).
-
Loss of DRD5P2 in hypoxia attenuates Rock2 degradation to promote EMT and gastric cancer metastasis. Biochim Biophys Acta Mol Basis Dis. 2025 Aug; 1871(6):167858.
-
Transforming malignant tumors into vulnerable phenotypes via nanoscale coordination polymer mediated cell senescence and photodynamic therapy. Biomaterials. 2025 Nov; 322:123355.
-
Tumour interstitial fluid-enriched phosphoethanolamine suppresses T cell function. Nat Cell Biol. 2025 May; 27(5):835-846.
-
PKCd Germline Variants and Genetic Deletion in Mice Augment Antitumor Immunity through Regulation of Myeloid Cells. Cancer Immunol Res. 2025 Apr 02; 13(4):547-559.